Related Experiment Video
Updated: Apr 23, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Current symptomatology in multiple sclerosis and neuromyelitis optica
1Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Several symptoms like Lhermitte's sign are more common in Neuromyelitis Optica Spectrum Disorder (NMOSD) than Multiple Sclerosis (MS). This suggests differences in inflammation and lesion characteristics between these central nervous system inflammatory diseases.
Area of Science:
- Neuroimmunology
- Central Nervous System Inflammatory Diseases
- Demyelinating Disorders
Background:
- Multiple Sclerosis (MS) and Neuromyelitis Optica Spectrum Disorder (NMOSD) are inflammatory central nervous system diseases.
- Some symptoms, such as Lhermitte's sign and Uhthoff's phenomenon, were historically considered characteristic of MS.
- A significant overlap exists, with opticospinal forms of MS often being reclassified as NMOSD.
Purpose of the Study:
- To investigate the frequency of MS-associated symptoms and signs in patients with NMOSD and MS.
- To identify clinical features that differentiate NMOSD from MS.
Main Methods:
- A comparative study of consecutive Japanese patients diagnosed with NMOSD (NMO or partial NMO) and MS.
- Data collected from patients seen at Chiba University Hospital between 2011 and 2012.
- Logistic regression analyses were employed to distinguish between NMOSD and MS based on symptom and sign frequencies.
Main Results:
- Univariate analysis indicated higher frequencies of tonic seizures, Lhermitte's sign, persistent pain, fatigue, and girdle sensation in NMOSD patients compared to MS patients.
- Multivariate logistic regression identified paroxysmal itching, Uhthoff's phenomenon, Lhermitte's sign, and girdle sensation as more characteristic of NMOSD than MS.
Conclusions:
- Certain classic MS symptoms are more prevalent in NMOSD patients.
- These differences may stem from variations in inflammatory severity, lesion localization, and extent in demyelinating diseases.
- Distinguishing clinical features can aid in differentiating NMOSD from MS.
Related Concept Videos
Multiple Sclerosis l: Introduction
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis ll: Pathophysiology
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myocarditis II: Clinical Features and Diagnostic Tests

